In-vitro models that maintain complex transport mechanisms and structural properties associated with the blood-brain barrier in vivo would be useful in drug permeability and neurotoxicological studies. To evaluate the suitability of a human retinal pigment epithelial cell line for a blood-brain barrier model, we have compared the barrier properties of the human retinal pigment epithelial cell line ARPE-19, the human colonic adenocarcinoma cell line Caco-2, and primary porcine microvessel endothelial cells. The tight junction proteins occludin and ZO-1 were stained immunocytochemically. The paracellular ionic permeability was evaluated by measuring the trans-epithelial or trans-endothelial electric resistance. To evaluate the active transport mechanisms, the existence and the activity of the efflux transporters, P-glycoprotein and multidrug resistance-associated proteins, were studied. All the cell types in this study stained positively for occludin and ZO-1. However, the trans-endothelial electric resistance of ARPE-19 cells was low compared with that of primary porcine microvessel endothelial cell and Caco-2 cells. In addition, both the P-glycoprotein expression and its activity in ARPE-19 cells were low. In conclusion, the barrier properties of the human ARPE-19 cell line were not satisfactory for a blood-brain barrier model. For future studies, it is important to develop a human brain endothelial cell line with expression of the complex in-vivo properties of the blood-brain barrier.
1 Ballabh P Braun A Nedergaard M . The blood-brain barrier: an overview: structure, regulation, and clinical implications. Neurobiol Dis2004; 16: 1–13.
3 Janzer RC Raff MC . Astrocytes induce blood-brain barrier properties in endothelial cells. Nature1987; 325: 253–257.
4.
4 Gaillard PJ Voorwinden LH Nielsen JL Ivanov A Atsumi R Engman H . Establishment and functional characterization of an in vitro model of the blood-brain barrier, comprising a co-culture of brain capillary endothelial cells and astrocytes. Eur J Pharm Sci2001; 12: 215–222.
5.
5 Jeliazkova-Mecheva VV Hymer WC Nicholas NC Bobilya DJ . Brief heat shock affects the permeability and thermotolerance of an in vitro blood-brain barrier model of porcine brain microvascular endothelial cells. Microvasc Res2006; 71: 108–114.
6.
6 Franke H Galla HJ Beuckmann CT . An improved low-permeability in vitro-model of the blood-brain barrier: transport studies on retinoids, sucrose, haloperidol, caffeine and mannitol. Brain Res1999; 818: 65–71.
7.
7 Miller DW Audus KL Borchardt RT . Application of cultured endothelial cells of the brain microvasculature in the study of the blood-brain barrier. J Tissue Cult Methods1992; 14: 217–224.
8.
8 Yang J Mutkus LA Sumner D Stevens JT Eldridge JC Strandhoy JW . Transendothelial permeability of chlorpyrifos in RBE4 monolayers is modulated by astrocyte-conditioned medium. Brain Res Mol Brain Res2001; 97: 43–50.
9.
9 Garberg P Ball M Borg N Cecchelli R Fenart L Hurst RD . In vitro models for the blood-brain barrier. Toxicol In Vitro2005; 19: 299–334.
10.
10 Cunha-Vaz JG . The blood-retinal barriers system. Basic concepts and clinical evaluation. Exp Eye Res2004; 78: 715–721.
11.
11 Toimela T Maenpaa H Mannerstrom M Tahti H . Development of an in vitro blood-brain barrier model-cytotoxicity of mercury and aluminum. Toxicol Appl Pharmacol2004; 195: 73–82.
12.
12 Kusch-Poddar M Drewe J Fux I Gutmann H . Evaluation of the immortalized human brain capillary endothelial cell line BB19 as a human cell culture model for the blood-brain barrier. Brain Res2005; 1064: 21–31.
13.
13 Weksler BB Subileau EA Perrière N Charneau P Holloway K Leveque M . Blood-brain barrier-specific properties of a human adult brain endothelial cell line. FASEB J2005; 13: 1872–1874.
14.
14 Gonzalez-Mariscal L Betanzos A Nava P Jaramillo BE . Tight junction proteins. Prog Biophys Mol Biol2003; 81: 1–44.
15.
15 Fromm MF . Importance of P-glycoprotein at blood-tissue barriers. Trends Pharmacol Sci2004; 25: 423–429.
16.
16 Fanning AS Jameson BJ Jesaitis LA Anderson JM . The tight junction protein ZO-1 establishes a link between the transmembrane protein occludin and the actin cytoskeleton. J Biol Chem1998; 273: 29745–29753.
17.
17 Furuse M Hirase T Itoh M Nagafuchi A Yonemura S Tsukita S . Occludin: a novel integral membrane protein localizing at tight junctions. J Cell Biol1993; 123: 1777–1788.
18.
18 Wolburg H Lippoldt A . Tight junctions of the blood-brain barrier: development, composition and regulation. Vascul Pharmacol2002; 38: 323–337.
19.
19 Fasano A Nataro JP . Intestinal epithelial tight junctions as targets for enteric bacteria-derived toxins. Adv Drug Deliv Rev2004; 56: 795–807.
20.
20 Ban Y Rizzolo LJ . A culture model of development reveals multiple properties of RPE tight junctions. Mol Vis1997; 3: 18–26.
21.
21 Borst P Evers R Kool M Wijnholds J . A family of drug transporters: the multidrug resistance-associated proteins. J Natl Cancer Inst2000; 92: 1295–1302.
22.
22 Hopper E Belinsky MG Zeng H Tosolini A Testa JR Kruh GD . Analysis of the structure and expression pattern of MRP7 (ABCC10), a new member of the MRP subfamily. Cancer Lett2001; 162: 181–191.
23.
23 Guo YP Kotova E Chen ZS Lee K Hopper-Borge E Belinsky MG . MRP8, ATP-binding cassette C11 (ABCC11), is a cyclic nucleotide efflux pump and a resistance factor for fluoropyrimidines 2',3'-dideoxycytidine and 9'-(2'-phosphonylmethoxyethyl) adenine. J Biol Chem2003; 278: 29509–29514.
24.
24 Sun J He ZG Cheng G Wang SJ Hao XH Zou MJ . Multidrug resistance P-glycoprotein: crucial significance in drug disposition and interaction. Med Sci Monit2004; 10: RA5–RA14.
25.
25 Schumacher U Mollgard K . The multidrug-resistance P-glycoprotein (Pgp, MDR1) is an early marker of blood-brain barrier development in the microvessels of the developing human brain. Histochem Cell Biol1997; 108: 179–182.
26.
26 Zhang Y Han HY Elmquist WF Miller DW . Expression of various multidrug resistance-associated protein (MRP) homologues in brain microvessel endothelial cells. Brain Res2000; 876: 148–153.
27.
27 Kim RB Fromm MF Wandel C Leake B Wood AJJ Roden DM . The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors. J Clin Invest1998; 101: 289–294.
28.
28 Zimmermann C Gutmann H Hruz P Gutzwiller JP Beglinger C Drewe J . Mapping of multidrug resistance gene 1 and multidrug resistance-associated protein isoform 1 to 5 mRNA expression along the human intestinal tract. Drug Metab Dispos2005; 33: 219–224.
29.
29 Kennedy BG Mangini NJ . P-glycoprotein expression in human retinal pigment epithelium. Mol Vis2002; 8: 422–430.
30.
30 Aukunuru JV Sunkara G Bandi N Thoreson WB Kompella UB . Expression of multidrug resistance-associated protein (MRP) in human retinal pigment epithelial cells and its interaction with BAPSG, a novel aldose reductase inhibitor. Pharm Res2001; 18: 565–572.
31.
31 Franke H Galla H Beuckmann CT . Primary cultures of brain microvessel endothelial cells: a valid and flexible model to study drug transport through the blood-brain barrier in vitro. Brain Res Brain Res Protoc2000; 5: 248–256.
32.
32 Voyta JC Via DP Butterfield CE Zetter BR . Identification and isolation of endothelial cells based on their increased uptake of acetylated-low density lipoprotein. J Cell Biol1984; 99: 2034–2040.
33.
33 Sharom FJ Yu X Lu P Liu R Chu JWK Szabó K . Interaction of the P-glycoprotein multidrug transporter (MDR1) with high affinity peptide chemosensitizers in isolated membranes, reconstituted systems, and intact cells. Biochem Pharmacol1999; 58: 571–586.
34.
34 Sun HY Johnson DR Finch RA Sartorelli AC Miller DW Elmquist WF . Transport of fluorescein in MDCKII-MRP1 transfected cells and mrp1-knockout mice. Biochem Biophys Res Commun2001; 284: 863–869.
35.
35 Huai-Yun H Secrest DT Mark KS Carney D Brandquist C Elmquist WF . Expression of multidrug resistance-associated protein (MRP) in brain microvessel endothelial cells. Biochem Biophys Res Commun1998; 243: 816–820.
36.
36 Steuer H Jaworski A Elger B Kaussmann M Keldenich J Schneider H . Functional characterization and comparison of the outer blood-retina barrier and the blood-brain barrier. Invest Ophthalmol Vis Sci2006; 46: 1047–1053.
37.
37 Taipalensuu J Tornblom H Lindberg G Einarsson C Sjoqvist F Melhus H . Correlation of gene expression of ten drug efflux proteins of the ATP-binding cassette transporter family in normal human jejunum and in human intestinal epithelial Caco-2 cell monolayers. J Pharmacol Exp Ther2001; 299: 164–170.
38.
38 Ranaldi G Consalvo R Sambuy Y Scarino ML . Permeability characteristics of parental and clonal human intestinal Caco-2 cell lines differentiated in serum-supplemented and serum-free media. Toxicol In Vitro2003; 17: 761–767.
39.
39 Hoheisel D Nitz T Franke H Wegener J Hakvoort A Tilling T . Hydrocortisone reinforces the blood-brain barrier properties in a serum free cell culture system. Biochem Biophys Res Commun1998; 244: 312–316.
40.
40 Nitz T Eisenblatter T Psathaki K Galla HJ . Serum-derived factors weaken the barrier properties of cultured porcine brain capillary endothelial cells in vitro. Brain Res2003; 981: 30–40.
41.
41 Jiang WG Bryce RP Horrobin DF Mansel RE . Regulation of tight junction permeability and occludin expression by polyunsaturated fatty acids. Biochem Biophys Res Commun1998; 244: 414–420.
42.
42 Igarashi Y Utsumi H Chiba H Yamada S Tobioka H Kamimura Y . Glial cell line-derived neurotrophic factor induces barrier function of endothelial cells forming the blood-brain barrier. Biochem Biophys Res Commun1999; 261: 108–112.
43.
43 Gonzalez-Mariscal L Nava P . Tight junctions, from tight intercellular seals to sophisticated protein complexes involved in drug delivery, pathogens interaction and cell proliferation. Adv Drug Deliv Rev2006; 57: 811–814.
44.
44 Hu J Bok D . A cell culture medium that supports the differentiation of human retinal pigment epithelium into functionally polarized monolayers. Mol Vis2000; 7: 14–19.
45.
45 Hagenbuch B Gao B Meier PJ . Transport of xenobiotics across the blood-brain barrier. News Physiol Sci2002; 17: 231–234.
46.
46 Constable PA Lawrenson JG Dolman DEM Arden GB Abbott NJ . P-glycoprotein expression in human retinal pigment epithelium cell lines. Exp Eye Res2006; 83: 24–30.
47.
47 Seelig A Blatter XL Wohnsland F . Substrate recognition by P-glycoprotein and the multidrug resistance-associated protein MRP1: a comparison. Int J Clin Pharmacol Ther2000; 38: 111–121.
48.
48 Bock U Flötotto T Haltner E . Validation of cell culture models for the intestine and the blood-brain barrier and comparison of drug permeation. ALTEX2004; 21(Suppl. 3): 57–64.
